ACET
Adicet Bio IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$75.25M
P/E Ratio
—
EPS
$-13.87
Beta
1.51
52W High
$17.44
52W Low
$6.01
50-Day MA
$7.83
200-Day MA
$9.33
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.82
About Adicet Bio Inc
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company is headquartered in Boston, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $24.99M |
| EBITDA | $-107.76M |
| Operating Margin | 0.00% |
| Return on Equity | -72.20% |
| Return on Assets | -39.40% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $14.59 |
| Price-to-Book | 0.50 |
| Price-to-Sales (TTM) | 9.72 |
| EV/Revenue | 2.139 |
| EV/EBITDA | -1.21 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $9.35M |
| Float | $5.83M |
| % Insiders | 0.91% |
| % Institutions | 63.61% |
Historical Volatility
HV 10-Day
90.38%
HV 20-Day
85.31%
HV 30-Day
77.35%
HV 60-Day
76.91%
HV Rank
62.3%
Volatility is currently expanding
Analyst Ratings
Consensus ($34.83 target)
6
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026